Hematopoietic stem cell transplantation for children with thalassemia major in china
Authors:
- 26 October 2010
- journal article
- review article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 55 (6) , 1062-1065
Abstract
Thalassemia is the most common single‐gene disorder worldwide that is considered a major public health issue. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for thalassemia major, the form of the disease reflecting homozygosity for a mutant allele. In China, many patients with thalassemia major cannot financially afford life‐long regular supportive care with blood transfusions and iron chelation. Although HSCT is expensive, it is a one‐time treatment that is possible in some patients. Disease‐free survival rates have been 52–82% after HSCT in China. Graft rejection is the main cause of failure following HSCT. Humoral immune activity may play an important role in engraftment of donor cells. This article reviews the current status of HSCT for children with thalassemia major in China. Pediatr Blood Cancer. 2010;55:1062–1065.Keywords
This publication has 23 references indexed in Scilit:
- Marrow graft rejection by repeated transfusions of allogeneic donor spleen cellsBone Marrow Transplantation, 2007
- Effectiveness of a nurse-led management programme for paediatric asthma in TaiwanJournal of Paediatrics and Child Health, 2007
- Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipientsBlood, 2006
- Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipientsBlood, 2006
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- Financial burden of national health insurance for treating patients with transfusion-dependent thalassemia in TaiwanBone Marrow Transplantation, 2006
- ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN β -THALASSEMIAPediatric Hematology and Oncology, 2002
- Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia RegisterThe Lancet, 2000
- Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsiesBritish Journal of Haematology, 1995
- Disorders of haemoglobin in China.Journal of Medical Genetics, 1987